Report Detail
Global Chimeric Antigen Receptor Cell Therapy Market Growth (Status and Outlook) 2019-2024
- RnM3411956 |
- 13 May, 2019 |
- Global |
- 152 Pages |
- LPI(LP Information) |
- Other
According to this study, over the next five years the Chimeric Antigen Receptor Cell Therapy market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Chimeric Antigen Receptor Cell Therapy business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Chimeric Antigen Receptor Cell Therapy market by product type, application, key companies and key regions.
This study considers the Chimeric Antigen Receptor Cell Therapy value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Monotherapy
Combination Therapy
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Acute Leukemia
Non-hodgkin's Lymphoma
Multiple Myeloma
Transplant Rejection
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Amgen Inc
Autolus Therapeutics Plc
Beijing Immunochina Medical Science & Technology Co Ltd
Bellicum Pharmaceuticals Inc
Bristol-Myers Squibb Co
bluebird bio Inc
CARsgen Therapeutics Ltd
Celgene Corp
Cell Medica Ltd
Cellular Biomedicine Group Inc
Celularity Inc
Celyad SA
Daiichi Sankyo Co Ltd
Fosun Pharmaceutical AG
Gilead Sciences Inc
Guangzhou Anjie Biomedical Technology Co Ltd
Hangzhou Converd Co Ltd
Hebei Senlang Biotechnology Inc Ltd
HRAIN Biotechnology Co Ltd
Juno Therapeutics Inc
Kite Pharma Inc
Nanjing Legend Biotech Co Ltd
NantKwest Inc
Nkarta Inc
Novartis AG
Ono Pharmaceutical Co Ltd
Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
Sorrento Therapeutics Inc
Takara Bio Inc
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Chimeric Antigen Receptor Cell Therapy market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Chimeric Antigen Receptor Cell Therapy market by identifying its various subsegments.
Focuses on the key global Chimeric Antigen Receptor Cell Therapy players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Chimeric Antigen Receptor Cell Therapy with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Chimeric Antigen Receptor Cell Therapy submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Chimeric Antigen Receptor Cell Therapy Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Chimeric Antigen Receptor Cell Therapy Market Size 2014-2024
- 2.1.2 Chimeric Antigen Receptor Cell Therapy Market Size CAGR by Region
- 2.2 Chimeric Antigen Receptor Cell Therapy Segment by Type
- 2.2.1 Monotherapy
- 2.2.2 Combination Therapy
- 2.3 Chimeric Antigen Receptor Cell Therapy Market Size by Type
- 2.3.1 Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate by Type (2014-2019)
- 2.4 Chimeric Antigen Receptor Cell Therapy Segment by Application
- 2.4.1 Acute Leukemia
- 2.4.2 Non-hodgkin's Lymphoma
- 2.4.3 Multiple Myeloma
- 2.4.4 Transplant Rejection
- 2.4.5 Other
- 2.5 Chimeric Antigen Receptor Cell Therapy Market Size by Application
- 2.5.1 Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate by Application (2014-2019)
3 Global Chimeric Antigen Receptor Cell Therapy by Players
- 3.1 Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Players
- 3.1.1 Global Chimeric Antigen Receptor Cell Therapy Market Size by Players (2017-2019)
- 3.1.2 Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Players (2017-2019)
- 3.2 Global Chimeric Antigen Receptor Cell Therapy Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Chimeric Antigen Receptor Cell Therapy by Regions
- 4.1 Chimeric Antigen Receptor Cell Therapy Market Size by Regions
- 4.2 Americas Chimeric Antigen Receptor Cell Therapy Market Size Growth
- 4.3 APAC Chimeric Antigen Receptor Cell Therapy Market Size Growth
- 4.4 Europe Chimeric Antigen Receptor Cell Therapy Market Size Growth
- 4.5 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size Growth
5 Americas
- 5.1 Americas Chimeric Antigen Receptor Cell Therapy Market Size by Countries
- 5.2 Americas Chimeric Antigen Receptor Cell Therapy Market Size by Type
- 5.3 Americas Chimeric Antigen Receptor Cell Therapy Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Chimeric Antigen Receptor Cell Therapy Market Size by Countries
- 6.2 APAC Chimeric Antigen Receptor Cell Therapy Market Size by Type
- 6.3 APAC Chimeric Antigen Receptor Cell Therapy Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Chimeric Antigen Receptor Cell Therapy by Countries
- 7.2 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Type
- 7.3 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Chimeric Antigen Receptor Cell Therapy by Countries
- 8.2 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Type
- 8.3 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Chimeric Antigen Receptor Cell Therapy Market Forecast
- 10.1 Global Chimeric Antigen Receptor Cell Therapy Market Size Forecast (2019-2024)
- 10.2 Global Chimeric Antigen Receptor Cell Therapy Forecast by Regions
- 10.2.1 Global Chimeric Antigen Receptor Cell Therapy Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Chimeric Antigen Receptor Cell Therapy Forecast by Type
- 10.8 Global Chimeric Antigen Receptor Cell Therapy Forecast by Application
11 Key Players Analysis
- 11.1 Amgen Inc
- 11.1.1 Company Details
- 11.1.2 Chimeric Antigen Receptor Cell Therapy Product Offered
- 11.1.3 Amgen Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Amgen Inc News
- 11.2 Autolus Therapeutics Plc
- 11.2.1 Company Details
- 11.2.2 Chimeric Antigen Receptor Cell Therapy Product Offered
- 11.2.3 Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 Autolus Therapeutics Plc News
- 11.3 Beijing Immunochina Medical Science & Technology Co Ltd
- 11.3.1 Company Details
- 11.3.2 Chimeric Antigen Receptor Cell Therapy Product Offered
- 11.3.3 Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 Beijing Immunochina Medical Science & Technology Co Ltd News
- 11.4 Bellicum Pharmaceuticals Inc
- 11.4.1 Company Details
- 11.4.2 Chimeric Antigen Receptor Cell Therapy Product Offered
- 11.4.3 Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 Bellicum Pharmaceuticals Inc News
- 11.5 Bristol-Myers Squibb Co
- 11.5.1 Company Details
- 11.5.2 Chimeric Antigen Receptor Cell Therapy Product Offered
- 11.5.3 Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 Bristol-Myers Squibb Co News
- 11.6 bluebird bio Inc
- 11.6.1 Company Details
- 11.6.2 Chimeric Antigen Receptor Cell Therapy Product Offered
- 11.6.3 bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 bluebird bio Inc News
- 11.7 CARsgen Therapeutics Ltd
- 11.7.1 Company Details
- 11.7.2 Chimeric Antigen Receptor Cell Therapy Product Offered
- 11.7.3 CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 CARsgen Therapeutics Ltd News
- 11.8 Celgene Corp
- 11.8.1 Company Details
- 11.8.2 Chimeric Antigen Receptor Cell Therapy Product Offered
- 11.8.3 Celgene Corp Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 Celgene Corp News
- 11.9 Cell Medica Ltd
- 11.9.1 Company Details
- 11.9.2 Chimeric Antigen Receptor Cell Therapy Product Offered
- 11.9.3 Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
- 11.9.4 Main Business Overview
- 11.9.5 Cell Medica Ltd News
- 11.10 Cellular Biomedicine Group Inc
- 11.10.1 Company Details
- 11.10.2 Chimeric Antigen Receptor Cell Therapy Product Offered
- 11.10.3 Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2017-2019)
- 11.10.4 Main Business Overview
- 11.10.5 Cellular Biomedicine Group Inc News
- 11.11 Celularity Inc
- 11.12 Celyad SA
- 11.13 Daiichi Sankyo Co Ltd
- 11.14 Fosun Pharmaceutical AG
- 11.15 Gilead Sciences Inc
- 11.16 Guangzhou Anjie Biomedical Technology Co Ltd
- 11.17 Hangzhou Converd Co Ltd
- 11.18 Hebei Senlang Biotechnology Inc Ltd
- 11.19 HRAIN Biotechnology Co Ltd
- 11.20 Juno Therapeutics Inc
- 11.21 Kite Pharma Inc
- 11.22 Nanjing Legend Biotech Co Ltd
- 11.23 NantKwest Inc
- 11.24 Nkarta Inc
- 11.25 Novartis AG
- 11.26 Ono Pharmaceutical Co Ltd
- 11.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
- 11.28 Sorrento Therapeutics Inc
- 11.29 Takara Bio Inc
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Chimeric Antigen Receptor Cell Therapy . Industry analysis & Market Report on Chimeric Antigen Receptor Cell Therapy is a syndicated market report, published as Global Chimeric Antigen Receptor Cell Therapy Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Chimeric Antigen Receptor Cell Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
